Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 35% ± 17% | |
brain | 19 studies | 48% ± 20% | |
eye | 12 studies | 40% ± 12% | |
kidney | 11 studies | 34% ± 12% | |
intestine | 10 studies | 38% ± 20% | |
heart | 6 studies | 24% ± 4% | |
prostate | 5 studies | 40% ± 3% | |
pancreas | 4 studies | 55% ± 21% | |
placenta | 4 studies | 39% ± 15% | |
uterus | 4 studies | 56% ± 10% | |
skin | 4 studies | 30% ± 7% | |
breast | 4 studies | 47% ± 13% | |
esophagus | 3 studies | 41% ± 26% | |
stomach | 3 studies | 42% ± 23% | |
thymus | 3 studies | 34% ± 16% | |
adipose | 3 studies | 20% ± 2% | |
liver | 3 studies | 43% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 26576.69 | 2642 / 2642 | 100% | 228.62 | 703 / 705 |
prostate | 100% | 31209.34 | 245 / 245 | 100% | 215.32 | 500 / 502 |
ovary | 100% | 26911.20 | 180 / 180 | 99% | 99.93 | 425 / 430 |
intestine | 100% | 18981.07 | 965 / 966 | 98% | 121.01 | 519 / 527 |
thymus | 100% | 13032.27 | 650 / 653 | 99% | 355.19 | 596 / 605 |
breast | 100% | 22942.98 | 459 / 459 | 98% | 85.76 | 1092 / 1118 |
stomach | 100% | 14907.58 | 359 / 359 | 97% | 101.40 | 276 / 286 |
kidney | 100% | 15970.60 | 89 / 89 | 96% | 138.71 | 869 / 901 |
lung | 100% | 19152.23 | 577 / 578 | 96% | 78.11 | 1114 / 1155 |
bladder | 100% | 19528.95 | 21 / 21 | 91% | 84.85 | 458 / 504 |
esophagus | 95% | 15875.99 | 1370 / 1445 | 93% | 65.49 | 171 / 183 |
uterus | 99% | 24927.18 | 169 / 170 | 88% | 81.31 | 404 / 459 |
skin | 93% | 8686.88 | 1689 / 1809 | 88% | 88.87 | 415 / 472 |
adrenal gland | 91% | 7386.51 | 234 / 258 | 84% | 65.09 | 193 / 230 |
liver | 64% | 3966.92 | 144 / 226 | 61% | 40.01 | 249 / 406 |
pancreas | 23% | 1102.23 | 75 / 328 | 98% | 108.01 | 175 / 178 |
blood vessel | 100% | 36608.52 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 19731.72 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 20538.37 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 11537.48 | 821 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 59.80 | 32 / 45 |
spleen | 40% | 1978.80 | 96 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 14.58 | 27 / 80 |
lymph node | 0% | 0 | 0 / 0 | 10% | 5.51 | 3 / 29 |
peripheral blood | 1% | 28.65 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_1902034 | Biological process | negative regulation of hematopoietic stem cell proliferation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0043068 | Biological process | positive regulation of programmed cell death |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TSC22D1 |
Protein name | TSC22 domain family protein 1 (Cerebral protein 2) (HUCEP-2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein) TSC22 domain family member 1 |
Synonyms | KIAA1994 TSC22 TGFB1I4 hucep-2 |
Description | FUNCTION: Transcriptional repressor . Acts on the C-type natriuretic peptide (CNP) promoter . Acts to promote CASP3-mediated apoptosis . Positively regulates TGF-beta signaling by interacting with SMAD7 which inhibits binding of SMAD7 to TGFBR1, preventing recruitment of SMURF ubiquitin ligases to TGFBR1 and inhibiting SMURF-mediated ubiquitination and degradation of TGFBR1 . Contributes to enhancement of TGF-beta signaling by binding to and modulating the transcription activator activity of SMAD4 . Promotes TGF-beta-induced transcription of COL1A2; via its interaction with TFE3 at E-boxes in the gene proximal promoter (By similarity). Plays a role in the repression of hematopoietic precursor cell growth (By similarity). Promotes IL2 deprivation-induced apoptosis in T-lymphocytes, via repression of TSC22D3/GILZ transcription and activation of the caspase cascade . .; FUNCTION: [Isoform 1]: May act to negatively regulate TGFB3 signaling and thereby inhibit cell death in mammary gland cells. .; FUNCTION: [Isoform 2]: Positively regulates cell death in response to TGFB3 during mammary gland involution. . |
Accessions | ENST00000261489.7 [Q15714-2] ENST00000493016.1 H7C4J9 ENST00000486464.1 ENST00000611198.4 [Q15714-5] C9IZ15 ENST00000472477.1 ENST00000622051.1 [Q15714-5] Q15714 ENST00000458659.3 [Q15714-1] C9JYW3 |